Abstract:Backgrounds: Inflammation plays an important role in all stages of atherosclerosis, but little is known about the therapeutic effects of quenching inflammation in atherosclerotic lesions formation.Purpose: Herein, the effect of artesunate, a derivant from artemisinin from the traditional Chinese herb sweet wormwood, could attenuate the progression of atherosclerosis lesion formation alone or combined with rosuvastatin in Western-type diet (WD) fed ApoE(-/)- mice, and explored its possible mechanisms.Methods: The methods such as ELISA for plasma lipids and cytokines analyses, qRT-PCR and western blot for mRNA and protein expressions, and MTT assay for human umbilical vein endothelial cells (HUVECs) viability were used for in vivo and in vitro experiments.Results: Artesunate could attenuate the progression of atherosclerosis lesion formation alone or combined with rosuvastatin in WD fed ApoE(-/-) mice without changes in food uptake, body weight and plasma lipids level, but with a significant reduction of pro-inflammatory cytokine, such as TNF-alpha and IL-6. Furthermore, artesunate could down-regulate the pro-inflammatory chemokines such as IL-8 and MCP-1 in aorta of mice. Besides, artesunate didn't influence IL-8 and MCP-1 secretion in HUVECs up-regulated by TNF-alpha, but inhibited IL-8 and MCP-1 secretion up-regulated by LPS.Conclusion: AS attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through anti-inflammatory effect, resulting in down-regulation of TNF-alpha and IL-6, and further down-regulating IL-8 and MCP-1 expressions in aorta of WD fed ApoE(-/-) mice. Rosuvastatin combined with artesunate could more effectively attenuate the progression of atherosclerosis lesions than when treated by one of them, demonstrating that lipid-lowering agents combined with anti-inflammatory agents could provide the greater benefit for cardiovascular disease patients. Artesunate is worth further investigating, as a candidate drug for the treatment of atherosclerosis. (C) 2016 Elsevier GmbH. All rights reserved.

Artemisinin Inhibits Monocyte Adhesion to HUVECs Through the NF-κB and MAPK Pathways in Vitro.

The Anti-Malarial Artemisinin Inhibits Pro-Inflammatory Cytokines Via the NF-ÎºB Canonical Signaling Pathway in PMA-induced THP-1 Monocytes

S‐Allyl‐L‐Cysteine Sulfoxide Inhibits Tumor Necrosis Factor‐Alpha Induced Monocyte Adhesion and Intercellular Cell Adhesion Molecule‐1 Expression in Human Umbilical Vein Endothelial Cells

Ginsenoside Rb1 Inhibits Tumor Necrosis Factor-Alpha-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cells

Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.

Artemisinin Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses By Inhibiting Nf-Kappa B Pathway In Microglia Cells

Artemisinin Inhibits Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and Matrix Metalloproteinase‐9 Expression Via a Protein Kinase Cδ/p38/extracellular Signal‐regulated Kinase Pathway in Phorbol Myristate Acetate‐induced THP‐1 Macrophages

Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathway

Artemisinin attenuated atherosclerosis in high-fat diet-fed ApoE-/- mice by promoting macrophage autophagy via AMPK/mTOR/ULK1 pathway.

Artemisinin protects endothelial function and vasodilation from oxidative damage via activation of PI3K/Akt/eNOS pathway

Effects of Astragali Radix Extract on the Vascular Cell Adhesion Molecule-1 Expression of Mice Vascular Endothelial Cell Induced by Tumor Necrosis Factor-α

Artemisinin Reduces Lipid Accumulation in Hepatocytes by Inhibition of CD36 Expression

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.

Artemisinin suppresses sympathetic hyperinnervation following myocardial infarction via anti-inflammatory effects

Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.

Uric Acid Promotes Chemokine and Adhesion Molecule Production in Vascular Endothelium Via Nuclear Factor-Kappa B Signaling

Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway

Artesunate Attenuated Progression of Atherosclerosis Lesion Formation Alone or Combined with Rosuvastatin Through Inhibition of Pro-Inflammatory Cytokines and Pro-Inflammatory Chemokines

Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.

Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions